Biotech · Private company
NMD Pharma A/S
Track this companyFree. Adds NMD Pharma A/S to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- NMD670Phase 2 · Charcot-Marie-Tooth DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- NMD670Phase 2 · Myasthenia GravisClinicalTrials.gov · fetched Nov 12, 2026
- NMD670Phase 2 · Spinal Muscular AtrophyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Safety and Efficacy of NMD670 in Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth DiseasePHASE2 · COMPLETED · started Sep 30, 2024ClinicalTrials.gov NCT06482437 · fetched Nov 12, 2026
- Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia GravisPHASE2 · RECRUITING · started May 16, 2024ClinicalTrials.gov NCT06414954 · fetched Nov 12, 2026
- Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular AtrophyPHASE2 · COMPLETED · started Sep 21, 2023ClinicalTrials.gov NCT05794139 · fetched Nov 12, 2026
- Observational Study of Neuromuscular Function in CMT Type 1&2 and Healthy ControlsCOMPLETED · started Apr 7, 2021ClinicalTrials.gov NCT04980807 · fetched Nov 12, 2026
- Investigating Loss of Neuromuscular Junction Transmission Fidelity in Older AdultsCOMPLETED · started Mar 16, 2021ClinicalTrials.gov NCT04904926 · fetched Nov 12, 2026